These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12175878)

  • 1. Alexander disease: a review and the gene.
    Johnson AB
    Int J Dev Neurosci; 2002; 20(3-5):391-4. PubMed ID: 12175878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GFAP and its role in Alexander disease.
    Quinlan RA; Brenner M; Goldman JE; Messing A
    Exp Cell Res; 2007 Jun; 313(10):2077-87. PubMed ID: 17498694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
    Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
    Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
    Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
    APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease.
    Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T
    Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.
    Der Perng M; Su M; Wen SF; Li R; Gibbon T; Prescott AR; Brenner M; Quinlan RA
    Am J Hum Genet; 2006 Aug; 79(2):197-213. PubMed ID: 16826512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GFAP mutations in Alexander disease.
    Li R; Messing A; Goldman JE; Brenner M
    Int J Dev Neurosci; 2002; 20(3-5):259-68. PubMed ID: 12175861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
    Hagemann TL; Connor JX; Messing A
    J Neurosci; 2006 Oct; 26(43):11162-73. PubMed ID: 17065456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alexander disease with occipital predominance and a novel c.799G>C mutation in the GFAP gene.
    Hinttala R; Karttunen V; Karttunen A; Herva R; Uusimaa J; Remes AM
    Acta Neuropathol; 2007 Nov; 114(5):543-5. PubMed ID: 17805552
    [No Abstract]   [Full Text] [Related]  

  • 10. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease.
    Sosunov AA; McKhann GM; Goldman JE
    Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
    Tian R; Gregor M; Wiche G; Goldman JE
    Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial fibrillary acidic protein is pathologically modified in Alexander disease.
    Lin NH; Jian WS; Snider N; Perng MD
    J Biol Chem; 2024 Jul; 300(7):107402. PubMed ID: 38782207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction.
    Hagemann TL; Gaeta SA; Smith MA; Johnson DA; Johnson JA; Messing A
    Hum Mol Genet; 2005 Aug; 14(16):2443-58. PubMed ID: 16014634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.
    Kondo T; Funayama M; Miyake M; Tsukita K; Era T; Osaka H; Ayaki T; Takahashi R; Inoue H
    Acta Neuropathol Commun; 2016 Jul; 4(1):69. PubMed ID: 27402089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation.
    Yoshida T; Nakagawa M
    Neuropathology; 2012 Aug; 32(4):440-6. PubMed ID: 22118268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers.
    Eng LF; Lee YL; Kwan H; Brenner M; Messing A
    J Neurosci Res; 1998 Aug; 53(3):353-60. PubMed ID: 9698163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease.
    Hagemann TL; Boelens WC; Wawrousek EF; Messing A
    Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP.
    Hsiao VC; Tian R; Long H; Der Perng M; Brenner M; Quinlan RA; Goldman JE
    J Cell Sci; 2005 May; 118(Pt 9):2057-65. PubMed ID: 15840648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Alexander disease: beyond the classical concept of leukodystrophy.
    Sawaishi Y
    Brain Dev; 2009 Aug; 31(7):493-8. PubMed ID: 19386454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease.
    Hagemann TL; Powers B; Mazur C; Kim A; Wheeler S; Hung G; Swayze E; Messing A
    Ann Neurol; 2018 Jan; 83(1):27-39. PubMed ID: 29226998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.